This enables next-day reporting and greater batch efficiency for high-throughput hospital needs. Combined with a simplified report format that combines the results of both qPCR and NGS tests, the ...

Peer-reviewed journal Clinical Chemistry published the first head-to-head study comparing GraftAssure™ to industry-leading ...

If you've ever taken an at-home diagnostic test for COVID-19, you can partially credit the technology to the Johns Hopkins University Center for Innovative Diagnostics for Infectious Diseases (CIDID).

This study evaluates inclusion of National Comprehensive Cancer Network (NCCN) guideline recommended biomarkers for metastatic non–small cell lung cancer (NSCLC) in commercially available targeted ...

Oct 3 (Reuters) - The World Health Organization authorized Abbott Laboratories' (ABT.N), opens new tab mpox diagnostic test for emergency use on Thursday, the first such approval in the agency's ...

A key microbial genome database is being updated and expanded through a public-private partnership, as the US Food and Drug Administration (FDA) works with a health data company and an academic ...

The global PD-L1 Biomarker Testing Market is witnessing robust expansion as precision oncology, immunotherapy adoption, and ...

Ongoing verification study supports compatibility of DeepChek® with the AVITI™ platform. Expands opportunities in ...

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today announced that it looks forward to working with the U.S.